Abstract:Objectives: To investigate the phenotype, genotype and prognosis of cblF disorder (CblF). Methodology: Data including newborn screening and clinical features, LMBRD1 mutations, treatment and prognosis of the first CblF case in China and 17 reported CblF cases were collected and analysed. Results: This case was picked up by newborn screening (NBS) due to elevated blood propionylcarnitine (C3) (5.50 mu mol/L), propionylcarnitine/acetylcarnitine (C3/C2) ratio (0.47), propionylcarnitine/free carnitine C3/C0 ratio (0.25) and decreased methionine (Met) (5.27 mu mol/L) identified by tandem mass spectrometry (MS-MS), then decreased serum Vitamin B-12 (cobalamin; Vit B-12) (116 pmol/L), elevated homocysteine (tHCY) (82.9 mu mol/L), macrocytic anaemia and atrial septal defect, and patent ductus arteriosus were confirmed. This is similar to what has been reported in the literature. Besides, two novel truncated LMBRD1 mutations of p.R277* and p.C29* were confirmed. The data of all the 18 cases show that the common clinical features are macrocytic anaemia, failure to thrive, developmental delay, congenital heart disease, and small for gestational age. Similar biochemical characters were identified in all 3 cases from NBS, and a total of 35 LMBRD1 mutations in 10 different sites including frame-shift mutations (30/35), splice site mutations (2/35), nonsense mutations (2/35), and large fragment deletions (1/35) were observed, among which c.1056delG mutation was reported the most frequently (24/35). After Vit B-12 injection and supportive treatment, all of the biochemical abnormalities and most of the clinical presentations have been significantly improved within 3 months in all cases. Conclusion: The biochemical characters of CblF are similar to the combined methylmalonic acid (MMA), except for decreased serum Vit B-12, which should be distinguished from Vit B-12 deficiency. Typical phenotype includes macrocytic anaemia, growth and development problems, and congenital malformations, all of which are nonspecific. The c.1056delG mutation is the common mutation. The concentrations of C3, C3/C2, C3/C0 and Met by MS-MS and the target genetic panel of MMA should be chosen for suspected MMA cases. CblF is a treatable disease, and injection of Vit B-12 is effective, but the appropriate dosage remains unclear.

A case of multiple carboxylase deficiency presenting with skin lesions as the initial symptom induced by a novel mutation in the holocarboxylase synthetase gene

A Case of Ichthyosis Follicularis, Atrichia and Photophobia Syndrome Caused by a Novel Mutation in the MBTPS2 Gene

Homocystinuria In A Family With Novel Cystathionine Beta Synthase Gene Mutations

[Genetic Analysis of Newborns with Abnormal Metabolism of 3-Hydroxyisovalerylcarnitine].

Case report of holocarboxylase synthetase deficiency (late-onset) in 2 Chinese patients

Clinical, Biochemical, and Genetic Analysis of 28 Chinese Patients with Holocarboxylase Synthetase Deficiency.

[Diagnosis, Treatment and Gene Mutation Analysis in Children with Holocarboxylase Synthetas Deficiency].

A new case of malonyl-CoA decarboxylase deficiency with mild clinical features.

Clinical and Biochemical Studies of Multiple Carboxylase Deficiency in Children

A case of malonyl coenzyme A decarboxylase deficiency with novel mutations and literature review

Gene mutation analyses in Chinese children with multiple carboxylase deficiency

[A Chinese Boy with Methylmalonic Aciduria Cblb Type and a Novel Mutation in the MMAB Gene].

The First Case of Cobalamin F Disorder in China: Report and Literature Review

[Clinical and genetic features of children with 3-methylcrotonyl-coenzyme A carboxylase deficiency: an analysis of six cases]

Case report: Two siblings with very late onset of holocarboxylase synthase deficiency and a mini-review

Case report: An asymptomatic mother with an inborn error of cobalamin metabolism (cblC) detected through high homocysteine levels during prenatal diagnosis

A report of a pedigree with compound heterozygous mutations in the SLC22A5 gene

Clinical and mutational features of maternal 3-methylcrotonyl-coenzyme deficiency

Methylmalonic aciduria combined with congenital adrenal hyperplasia:a case report

Two novel mutations in the CPS 1 gene of a newborn with carbamoyl phosphate synthetase 1 deficiency identified by next-generation sequencing

Easily Misdiagnosed cblC Deficiency in Adolescents: the Clinical and Metabolic Studies